A Review of Current Diagnosis Strategies and Treatment Options for Major Depressive Disorder
Posted on: Thursday, 27 September 2007, 09:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c69791) has announced the addition of Disease and Therapy Review: Major Depressive Disorder to their offering.
The Major Depressive Disorder Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments, including SSRIs and atypical antidepressants, tricyclic antidepressants, monoamine oxidase inhibitors, and non-drug therapies. Dosing information and treatment costs are provided for a wide range of products. General information is included on the size of the US market for SSRIs.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Report Overview
I. OVERVIEW
II. INCIDENCE AND PREVALENCE
Incidence Table: (Worldwide)
Prevalence Table: (US, Canada, UK, France, Germany, Spain, Japan, China, Mexico, Worldwide)
III. DIAGNOSIS
IV. TREATMENT
SSRIs and Atypical Antidepressants
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Electroconvulsive Therapy
Phototherapy
Experimental Treatments
Psychological
Social
V. DOSING AND TREATMENT COSTS
VI MARKET SIZE
VII. COMMENTS
VIII. REFERENCES/RESOURCES
For more information visit http://www.researchandmarkets.com/reports/c69791
Source: Business Wire
Related Articles
- Reportlinker Adds Renal Disease Treatments: Products and Therapies
- Reportlinker Adds Liver Disease Treatments: The Global Market Report
- Heart Disease Treatment Breakthrough
- Stem cells to aid oral disease treatments
- Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation
- The Book 'Managing Chronic Obstructive Pulmonary Disease' Provides Insight into the Management of COPD at Home and in Hospital; Including Drug Treatments, Oxygen Therapy, and Non-Invasive Ventilation is Discussed
- The Systemic Lupus Erythematosus Disease And Therapy Review Provides Incidence And Prevalence Numbers And Percentages For Major Countries Worldwide
- Riverside Community Hospital Urges Registered Nurse Not to Report Serious Patient Care Incidents to Department of Health Services
- Protein May Aid Some Disease Treatments
- The Most Prevalent and Costly Diseases in the U.S. Detailed in a New Disease Incidence and Prevalence Report Published By Medtech Insight
 |
 |
User Comments (0)
RSS Feeds